Artificial intelligence tools are increasingly being developed to predict cancer biology directly from microscope images, ...

University of Warwick research warns that popular deep learning systems trained for cancer pathology may be relying on hidden ...

Scientists at Duke-NUS Medical School have identified a molecular "switch" that determines whether pancreatic cancer cells resist chemotherapy or respond to it—a finding that could help convert some ...

A new review article highlights the transformative role of circular RNA (circRNA) in cancer, revealing its potential as both a key player in tumor biology and a promising avenue for future therapies.

ADAM proteins, a family of a disintegrin and metalloproteinases, are pivotal regulators of cell signalling and adhesion, primarily through their ability to mediate ectodomain shedding. This process ...

When cancer-driving proteins resist various treatments, Northwestern University scientists have uncovered a new solution. Don't fight them—throw them in the cellular trash. In a new study published in ...

Cancer therapy and synthetic biology are converging around a shared problem that has long frustrated oncologists and engineers alike: the unpredictable behavior of individual cells. New work at the ...

The Undergraduate Cancer Biology Society (UCBS) was started in 2022 with inaugural President Sarah Elimam. Now our third year as a UAB Registered Student Organization, UCBS is excited to continue its ...

Caveolin-1 (Cav-1) is a principal scaffolding protein that orchestrates the formation of caveolae—specialised lipid microdomains within the plasma membrane. Its functions extend to the regulation of ...

Dr. Anczukow is a leading cancer biologist with expertise in RNA biology, molecular and cell biology, as well as human genetics, cancer biology, and genomics ...

The Liu Lab investigates cancer as a dynamic system shaped by interactions between tumor cells, their microenvironment, and intrinsic stress-response pathways. Our work focuses on identifying ...

Scientists at Duke-NUS Medical School have identified a molecular “switch” that determines whether pancreatic cancer cells resist chemotherapy or respond to it—a finding that could help convert some ...